| DB ID | MyCo_3747 |
| Title | Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection |
| Year | 2021 |
| PMID | 34075329 |
| Fungal Diseases involved | Mucormycosis |
| Disease | Mucormycosis |
| Associated Medical Condition | COVID-19 |
| Genus | Unclassified |
| Species | Unclassified |
| Organism | Unclassified |
| Ethical Statement | Not required. |
| Site of Infection | Unspecified |
| Opportunistic invasive | Opportunistic |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Negative |
| Biomolecule | Protein |
| Geographical Location | UK |
| Cohort | In April 2020, a 22-year-old Asian-descent male with a body mass index of 44 and a known history of hypothyroidism was transferred to our ICU with severe COVID pneumonitis requiring mechanical ventilation and an acute ACA territory cerebrovascular event (CVA). |
| Cohort No. | 1 |
| Age Group | 22 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Lateral flow |
| Technique | Immunoassay |
| Analysis Method | GM Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | GM Assay |
| Up Regulation Down Regulation | Negative |
| Sequence Data | None |
